Skip to main content

Baird Melissa's Form 4/A amendment

Amended

Hims & Hers Health, Inc. (HIMS) · filed Oct 6, 2023

Accession no.
0001773751-23-000268
Filed
Oct 6, 2023
Trade date
Oct 3-4, 2023
Filing delay
3 days
Rule 10b5-1 plan
Checked
Original filed
Oct 4, 2023

This filing lists 2 non-derivative transactions. Open-market sales total $114.2K. It was filed 3 days after the trade.

This amendment replaces 0001773751-23-000263 (filed Oct 4, 2023).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Baird MelissaCIK 0001837815Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 3, 2023Class A Common StockSSaleDisposed−9,133$6.32F2−$57,720.56422,115Direct
Oct 4, 2023Class A Common StockSSaleDisposed−9,133$6.18F3−$56,441.94412,982Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person.

F2

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $6.175 - $6.445. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $6.11- $6.26. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)